AVILAR THERAPEUTICS, INC.

Profile

Company Names

AVILAR THERAPEUTICS, INC.

Addresses

400 TOTTEN POND ROAD, SUITE 110, WALTHAM, MA 02451

200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA 02116

Phone Numbers

617-475-8493

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

MASSACHUSETTS

Total Amount Raised:

$75,276,164.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-12-14 
$75,276,164.00 
$75,276,164.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THERESA 
 
CAMERON 
DIRECTOR
AVILAR THERAPEUTICS, INC.
MILIND 
 
DESHPANDE 
EXECUTIVE OFFICER, DIRECTOR
SPERO THERAPEUTICS, LLC   |  NAYAN THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  SPERO THERAPEUTICS, INC.   |  TRIANA BIOMEDICINES, INC.
MARTIN 
 
FREED 
DIRECTOR
CIVITAS THERAPEUTICS, INC.   |  SOJOURNIX, INC.   |  SOLID BIOSCIENCES INC.   |  AVILAR THERAPEUTICS, INC.
PHIL 
 
GRAHAM 
EXECUTIVE OFFICER
AVILAR THERAPEUTICS, INC.
DANIEL 
 
GRAU 
EXECUTIVE OFFICER, DIRECTOR
CORTRIA CORP   |  TETRAGENETICS INC   |  LUSARIS THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.
PAULINA 
 
HILL 
DIRECTOR
FARADAY PHARMACEUTICALS, INC.   |  NEXTPOINT THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  JW CELTICS INVESTMENT CORP.   |  NORMUNITY HOLDING COMPANY, LLC   |  ODYSSEY THERAPEUTICS, INC.
ADAM 
 
MUZIKANT 
EXECUTIVE OFFICER
AVILAR THERAPEUTICS, INC.
DAVID 
 
NEAFUS 
EXECUTIVE OFFICER
SUSTAINX INC   |  AFFERENT PHARMACEUTICALS, INC.   |  PANGENX, INC.   |  MICROCHIPS BIOTECH, INC.   |  SYNDEVRX INC   |  ARRAKIS THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  NAYAN THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  KERA THERAPEUTICS, INC.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
JOSHUA 
 
RESNICK 
DIRECTOR
JERICHO CAPITAL PARTNERS, L.P.   |  COAXIA INC   |  JERICHO CAPITAL INTERNATIONAL LTD.   |  LIVESTREAM, LLC   |  JERICHO CAPITAL PARTNERS L.P.   |  SUGARFINA, LLC   |  RANA THERAPEUTICS, LLC   |  MIRAGEN THERAPEUTICS, INC.   |  JERICHO CAPITAL SPECIAL OPPORTUNITIES LTD   |  AVROBIO, INC.   |  SUGARFINA, INC.   |  RIBOMETRIX, INC.   |  NAYAN THERAPEUTICS, INC.   |  JERICHO ASIA OPPORTUNITIES LTD.   |  ATHENEN THERAPEUTICS, INC.   |  ARCUATE THERAPEUTICS, INC.   |  AEROVATE THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  VOR BIOPHARMA INC.   |  AVILAR THERAPEUTICS, INC.   |  PEPGEN INC.   |  TRIANA BIOMEDICINES, INC.   |  ALIADA THERAPEUTICS, INC.   |  OPENSKY VENTURES FUND I, LP
STEPHANIE 
 
TOZZO 
EXECUTIVE OFFICER
AVILAR THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-02-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-14 
2020-12-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#